These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19688784)

  • 1. Activity-based probes for monitoring postproline protease activity.
    Sabidó E; Tarragó T; Niessen S; Cravatt BF; Giralt E
    Chembiochem; 2009 Sep; 10(14):2361-6. PubMed ID: 19688784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carboxypeptidase in prolyl oligopeptidase family: Unique enzyme activation and substrate-screening mechanisms.
    Yadav P; Goyal VD; Gaur NK; Kumar A; Gokhale SM; Jamdar SN; Makde RD
    J Biol Chem; 2019 Jan; 294(1):89-100. PubMed ID: 30409909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolyl peptidases: a serine protease subfamily with high potential for drug discovery.
    Rosenblum JS; Kozarich JW
    Curr Opin Chem Biol; 2003 Aug; 7(4):496-504. PubMed ID: 12941425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structures of prolyl oligopeptidase substrate/inhibitor complexes. Use of inhibitor binding for titration of the catalytic histidine residue.
    Fülöp V; Szeltner Z; Renner V; Polgár L
    J Biol Chem; 2001 Jan; 276(2):1262-6. PubMed ID: 11031266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulating the selectivity of inhibitors for prolyl oligopeptidase inhibitors and fibroblast activation protein-α for different indications.
    Plescia J; Hédou D; Pousse ME; Labarre A; Dufresne C; Mittermaier A; Moitessier N
    Eur J Med Chem; 2022 Oct; 240():114543. PubMed ID: 35797897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biological role of prolyl oligopeptidase and the procognitive potential of its peptidic inhibitors from food proteins.
    Taraszkiewicz A; Sinkiewicz I; Sommer A; Staroszczyk H
    Crit Rev Food Sci Nutr; 2024; 64(19):6567-6580. PubMed ID: 36798052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the Conformational Dynamics of Prolyl Oligopeptidase by Mass Spectrometry: Lessons Learned.
    Van Elzen R; Konijnenberg A; Van der Veken P; Edgeworth MJ; Scrivens JH; Fülöp V; Sobott F; Lambeir AM
    J Med Chem; 2024 Jun; 67(12):10436-10446. PubMed ID: 38783480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The noncatalytic beta-propeller domain of prolyl oligopeptidase enhances the catalytic capability of the peptidase domain.
    Szeltner Z; Renner V; Polgár L
    J Biol Chem; 2000 May; 275(20):15000-5. PubMed ID: 10747969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of the substrate preferences of two post-proline cleaving endopeptidases, prolyl oligopeptidase and fibroblast activation protein α.
    Jambunathan K; Watson DS; Endsley AN; Kodukula K; Galande AK
    FEBS Lett; 2012 Jul; 586(16):2507-12. PubMed ID: 22750443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis.
    Tenorio-Laranga J; Coret-Ferrer F; Casanova-Estruch B; Burgal M; García-Horsman JA
    J Neuroinflammation; 2010 Apr; 7():23. PubMed ID: 20370893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide length and leaving-group sterics influence potency of peptide phosphonate protease inhibitors.
    Brown CM; Ray M; Eroy-Reveles AA; Egea P; Tajon C; Craik CS
    Chem Biol; 2011 Jan; 18(1):48-57. PubMed ID: 21276938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The structure and molecular dynamics of prolyl oligopeptidase from Microbulbifer arenaceous provide insights into catalytic and regulatory mechanisms.
    Huang P; Lv A; Yan Q; Jiang Z; Yang S
    Acta Crystallogr D Struct Biol; 2022 Jun; 78(Pt 6):735-751. PubMed ID: 35647921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploration of the one-bead one-compound methodology for the design of prolyl oligopeptidase substrates.
    Comellas G; Kaczmarska Z; Tarragó T; Teixidó M; Giralt E
    PLoS One; 2009 Jul; 4(7):e6222. PubMed ID: 19593439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low barrier hydrogen bond is absent in the catalytic triads in the ground state but Is present in a transition-state complex in the prolyl oligopeptidase family of serine proteases.
    Kahyaoglu A; Haghjoo K; Guo F; Jordan F; Kettner C; Felföldi F; Polgár L
    J Biol Chem; 1997 Oct; 272(41):25547-54. PubMed ID: 9325271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate and cyclosporine treatments modify the activities of dipeptidyl peptidase IV and prolyl oligopeptidase in murine macrophages.
    Olivo RA; Nascimento NG; Teixeira CF; Silveira PF
    Clin Dev Immunol; 2008; 2008():794050. PubMed ID: 18354729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Bisbenzamidine Phosphonate as a Janus-faced Inhibitor for Trypsin-like Serine Proteases.
    Häußler D; Scheidt T; Stirnberg M; Steinmetzer T; Gütschow M
    ChemMedChem; 2015 Oct; 10(10):1641-6. PubMed ID: 26306030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational Analysis of the Domain Architecture and Substrate-Gating Mechanism of Prolyl Oligopeptidases from Shewanella woodyi and Identification of Probable Lead Molecules.
    Patil P; Skariyachan S; Mutt E; Kaushik S
    Interdiscip Sci; 2016 Sep; 8(3):284-93. PubMed ID: 26298583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Issues about the physiological functions of prolyl oligopeptidase based on its discordant spatial association with substrates and inconsistencies among mRNA, protein levels, and enzymatic activity.
    Myöhänen TT; García-Horsman JA; Tenorio-Laranga J; Männistö PT
    J Histochem Cytochem; 2009 Sep; 57(9):831-48. PubMed ID: 19687473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methionine residues lining the substrate pathway in prolyl oligopeptidase from Pleurotus eryngii play an important role in substrate recognition.
    Tokai S; Bito T; Shimizu K; Arima J
    Biosci Biotechnol Biochem; 2018 Jul; 82(7):1107-1115. PubMed ID: 29623768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evaluation of caffeoyl and cinnamoyl derivatives as potential prolyl oligopeptidase inhibitors.
    Adolpho LO; Marin D; Puigpinos A; Mendieta L; Tarragó T; Morel AF; Giralt E; Dalcol II
    Planta Med; 2013 Nov; 79(16):1531-5. PubMed ID: 24085498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.